Effect Of Type 2 Diabetes Mellitus On Patients With Hepatocellular Carcinoma

Authors: Shoaib Ansari, Muhammad Sadik Memon, Rafi Ahmed Ghori

LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES, JAMSHORO/ HYDERABAD SINDH, PAKISTAN
ISRA UNIVERSITY HOSPITAL HYDERABAD, SINDH, PAKISTAN
LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES JAMSHORORO, SINDH PAKISTAN

Volume 15 | Issue 3

Published: November 12, 2026

Abstract

The management of hepatocellular carcinoma is influenced not only by
the tumour status and underlying liver function but also by any comorbid illness in the
patients and diabetes mellitus is one of them. The present study was undertaking to
evaluate the effect of diabetes mellitus on hepatocellular carcinoma. Study Design: Observational descriptive study. Place And Duration: This study was conducted in the department of Medicine Liaquat University Hospital and Isra University Hospital, Hyderabad from November 2005 to October 2008. Material And Methods: Total of 200 patients of HCC were analyzed. They were divided into two groups with and without diabetes mellitus. Clinical status and laboratory findings were noted and patients were followed for one year to see the prognosis in both groups. RESULTS: There were 200 patients in this study with mean age + SD of the patients were 53.70 + 12 years. Amongst all cases of HCC 165(85.57%) were males and 35(17.0%) were females, 46(23.0%) were diabetic and 154(77.0%) were non diabetic. Alfa fetoprotein
level was compared between two groups and we found that alfafetoprotein level was
2737.84+4149.564 ng/L in diabetics group whereas it was 11827.31+29287.392 ng/L in non-diabetics group (P = 0.03) which is statistically significant. In diabetic group one
year mortality was 68.42% whereas in non diabetic group one year mortality was 45.23%(P = 0.03). Conclusion: The overall survival rate in diabetic group was significantly lower than those the in non-diabetic group. Alpha fetoprotein level was significantly low in diabetic than in non-diabetic group.

Keywords: Hepatocellular carcinoma, Diabetes Mellitus, Alfa fetoprotein

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF